PubMed · 11106789
Endocannabinoids as cardiovascular modulators.
Abstract
Cannabinoids, the bioactive constituents of the marijuana plant and their synthetic and endogenous analogs cause not only neurobehavioral, but also cardiovascular effects. The most important component of these effects is a profound decrease in blood pressure and heart rate. Although multiple lines of evidence indicate that the hypotensive and bradycardic effects of anandamide and other cannabinoids are mediated by peripherally located CB1 cannabinoid receptors, anandamide can also elicit vasodilation in certain vascular beds, which is independent of CB1 or CB2 receptors. Possible cellular mechanisms underlying these effects and the cellular sources of vasoactive anandamide are discussed.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
G Kunos, Z Járai, S Bátkai, S K Goparaju, E J Ishac, J Liu, L Wang, J A Wagner. 2000. Endocannabinoids as cardiovascular modulators.. https://doi.org/10.1016/s0009-3084(00)00194-8. https://pubmed.health/record/pubmed%3A11106789/endocannabinoids-as-cardiovascular-modulators
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.